DA
ICPT

Duality Advisers’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Duality Advisers’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-51,196
Closed -$760K – 725
2021
Q3 		$760K Sell
51,196
-52,271
-51% -$836K 0.06% 389
2021
Q2 		$2.07M Sell
103,467
-2,201
-2% -$43.6K 0.18% 197
2021
Q1 		$2.44M Sell
105,668
-23,717
-18% -$661K 0.21% 167
2020
Q4 		$3.2M Buy
129,385
+98,685
+321% +$3.27M 0.24% 115
2020
Q3 		$1.27M Buy
+30,700
New +$1.41M 0.08% 317

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Duality Advisers's ICPT Position: Q4 2021 in Review

Duality Advisers sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2021, closing a stake of 51,196 shares — an estimated $760K sold.

Duality Advisers first reported a position in ICPT in Q3 2020 and held it in 5 quarters. The position peaked at $3.2M in Q4 2020. 147 funds tracked by Wall St. Rank hold ICPT as of Q4 2021.

  • Duality Advisers reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
  • Duality Advisers sold 51,196 Intercept Pharmaceuticals, Inc. shares in Q4 2021, an estimated $760K.
  • Duality Advisers first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2020 and held it in 5 quarters.
  • Duality Advisers's Intercept Pharmaceuticals, Inc. position peaked at $3.2M in Q4 2020.
  • 147 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2021.

Based on Duality Advisers's 13F filing for Q4 2021, filed 2 Feb 2022.